Two groups of anti-MNDAR encephalitis patients with different short-term outcomes had significant statistical differences in anti-infective therapy before admission, mRS score upon admission, seizures, autonomic dysfunction, consciousness declination, pneumonia, ICU admission, WBC, CRP, neutrophil percentage, albumin, and NPAR. The gene discussed is ALB; the disease is susceptibility to pneumonia measurement.